Lifevantage (NASDAQ:LFVN) Shares Cross Below Two Hundred Day Moving Average – Here’s Why

Lifevantage Corporation (NASDAQ:LFVN) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $8.19 and traded as low as $4.49. Lifevantage shares last traded at $4.59, with a volume of 173,327 shares trading hands.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on LFVN shares. Lake Street Capital reiterated a “buy” rating on shares of Lifevantage in a report on Thursday, February 5th. Loop Capital set a $5.00 price target on shares of Lifevantage in a research report on Thursday, February 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Lifevantage in a research note on Monday, December 29th. Finally, Wall Street Zen cut Lifevantage from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $5.00.

Lifevantage Stock Performance

The company has a market capitalization of $58.72 million, a PE ratio of 7.65 and a beta of 0.33. The business’s 50-day moving average is $5.78 and its 200-day moving average is $8.19.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). Lifevantage had a return on equity of 29.59% and a net margin of 3.74%.The business had revenue of $48.93 million during the quarter, compared to analysts’ expectations of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 3.9%. The ex-dividend date of this dividend is Monday, March 2nd. Lifevantage’s dividend payout ratio (DPR) is 30.00%.

Institutional Investors Weigh In On Lifevantage

A number of institutional investors have recently modified their holdings of LFVN. Virtu Financial LLC purchased a new position in shares of Lifevantage in the 4th quarter worth about $146,000. Invesco Ltd. increased its stake in Lifevantage by 13.6% during the 4th quarter. Invesco Ltd. now owns 30,085 shares of the company’s stock valued at $185,000 after purchasing an additional 3,603 shares in the last quarter. XTX Topco Ltd bought a new stake in Lifevantage during the 4th quarter valued at about $206,000. AQR Capital Management LLC raised its holdings in Lifevantage by 141.5% in the fourth quarter. AQR Capital Management LLC now owns 56,289 shares of the company’s stock worth $347,000 after buying an additional 32,985 shares during the last quarter. Finally, Cetera Investment Advisers lifted its stake in shares of Lifevantage by 29.4% in the fourth quarter. Cetera Investment Advisers now owns 25,405 shares of the company’s stock worth $156,000 after buying an additional 5,771 shares in the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.